Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

236 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Long term results of a phase II trial of hypofractionated adjuvant radiotherapy for early-stage breast cancer with volumetric modulated arc therapy and simultaneous integrated boost.
Franceschini D, Fogliata A, Spoto R, Dominici L, Lo Faro L, Franzese C, Comito T, Lobefalo F, Reggiori G, Cozzi L, Sagona A, Gentile D, Scorsetti M. Franceschini D, et al. Radiother Oncol. 2021 Nov;164:50-56. doi: 10.1016/j.radonc.2021.09.006. Epub 2021 Sep 17. Radiother Oncol. 2021. PMID: 34537289 Clinical Trial.
Radiotherapy boost dose-escalation for invasive breast cancer after breast-conserving surgery: 2093 patients treated with a prospective margin-directed policy.
Livi L, Meattini I, Franceschini D, Saieva C, Meacci F, Marrazzo L, Gerlain E, Desideri I, Scotti V, Nori J, Sanchez LJ, Orzalesi L, Bonomo P, Greto D, Bianchi S, Biti G. Livi L, et al. Among authors: franceschini d. Radiother Oncol. 2013 Aug;108(2):273-8. doi: 10.1016/j.radonc.2013.02.009. Epub 2013 Mar 13. Radiother Oncol. 2013. PMID: 23490271
Role of radiotherapy boost in women with ductal carcinoma in situ: a single-center experience in a series of 389 patients.
Meattini I, Livi L, Franceschini D, Saieva C, Meacci F, Marrazzo L, Bendinelli B, Scotti V, De Luca Cardillo C, Nori J, Sanchez L, Orzalesi L, Bonomo P, Greto D, Bucciolini M, Bianchi S, Biti G. Meattini I, et al. Among authors: franceschini d. Eur J Surg Oncol. 2013 Jun;39(6):613-8. doi: 10.1016/j.ejso.2013.03.002. Epub 2013 Mar 20. Eur J Surg Oncol. 2013. PMID: 23523088
Toxicity profile and early clinical outcome for advanced head and neck cancer patients treated with simultaneous integrated boost and volumetric modulated arc therapy.
Franzese C, Fogliata A, Clerici E, Franceschini D, Villa E, D'Agostino G, Navarria P, Mancosu P, Tomatis S, Cozzi L, Scorsetti M. Franzese C, et al. Among authors: d agostino g, franceschini d. Radiat Oncol. 2015 Nov 6;10:224. doi: 10.1186/s13014-015-0535-0. Radiat Oncol. 2015. PMID: 26545871 Free PMC article.
Hypo-fractionated stereotactic radiotherapy alone using volumetric modulated arc therapy for patients with single, large brain metastases unsuitable for surgical resection.
Navarria P, Pessina F, Cozzi L, Ascolese AM, De Rose F, Fogliata A, Franzese C, Franceschini D, Tozzi A, D'Agostino G, Comito T, Iftode C, Maggi G, Reggiori G, Bello L, Scorsetti M. Navarria P, et al. Among authors: d agostino g, franceschini d. Radiat Oncol. 2016 Jun 2;11:76. doi: 10.1186/s13014-016-0653-3. Radiat Oncol. 2016. PMID: 27249940 Free PMC article.
Can Stereotactic Body Radiation Therapy Be a Viable and Efficient Therapeutic Option for Unresectable Locally Advanced Pancreatic Adenocarcinoma? Results of a Phase 2 Study.
Comito T, Cozzi L, Clerici E, Franzese C, Tozzi A, Iftode C, Navarria P, D'Agostino G, Rimassa L, Carnaghi C, Personeni N, Tronconi MC, De Rose F, Franceschini D, Ascolese AM, Fogliata A, Tomatis S, Santoro A, Zerbi A, Scorsetti M. Comito T, et al. Among authors: d agostino g, franceschini d. Technol Cancer Res Treat. 2017 Jun;16(3):295-301. doi: 10.1177/1533034616650778. Epub 2016 Jun 16. Technol Cancer Res Treat. 2017. PMID: 27311310 Free PMC article. Clinical Trial.
236 results